Cim Investment Management Inc. Sells 308 Shares of UnitedHealth Group Incorporated $UNH

Cim Investment Management Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 2,361 shares of the healthcare conglomerate’s stock after selling 308 shares during the quarter. Cim Investment Management Inc.’s holdings in UnitedHealth Group were worth $1,237,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its holdings in UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after acquiring an additional 1,465 shares during the last quarter. Caitlin John LLC grew its holdings in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group in the 4th quarter worth $515,000. Finally, Silvercrest Asset Management Group LLC grew its holdings in UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after acquiring an additional 12,550 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. Wall Street Zen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, Morgan Stanley dropped their target price on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating for the company in a research report on Wednesday, August 20th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $355.77.

UnitedHealth Group Trading Up 2.1%

Shares of NYSE UNH opened at $353.89 on Friday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market cap of $320.51 billion, a P/E ratio of 15.33, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45. The firm has a 50-day moving average of $291.11 and a 200 day moving average of $370.48. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.